ArticleClinical and translational science2025

Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer.

Carlos Fernandez Teruel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.